Skip to Content

Join the 'Schizophrenia' group to help and get support from people like you.

Schizophrenia News

Related terms: Catatonic Schizophrenia, Disorganized Schizophrenia, Paranoid Schizophrenia, Residual Schizophrenia, Schizophrenia, catatonic, Schizophrenia, disorganized, Schizophrenia, paranoid, Schizophrenia, residual, Schizophrenia, undifferentiated, Undifferentiated Schizophrenia

Antipsychotic Meds Pose Little Danger to Fetus, Study Finds

Posted 12 days ago by Drugs.com

WEDNESDAY, Aug. 17, 2016 – Taking antipsychotic medicines in early pregnancy does not significantly increase the risk of birth defects, a new study finds. "In general, the use of any medication should be avoided during pregnancy [if possible]," explained study co-author Krista Huybrechts of Brigham and Women's Hospital in Boston. "However, for women suffering from schizophrenia, bipolar disorder, or major depressive disorder, avoiding medication use is often impossible, given that there are very few alternative treatment options," she said in a hospital news release. But how safe is exposure to these drugs for the developing fetus? To find out, Huybrecht's team tracked Medicaid data on 1.3 million pregnant women in order to assess the effects of older (typical) antipsychotic drugs and newer (atypical) versions, which are less likely to affect fertility. The study focused on the most ... Read more

Related support groups: Birth Control, Depression, Contraception, Bipolar Disorder, Seroquel, Major Depressive Disorder, Abilify, Schizophrenia, Latuda, Zyprexa, Risperdal, Schizoaffective Disorder, Risperidone, Geodon, Saphris, Quetiapine, Seroquel XR, Olanzapine, Delivery, Invega

Study of Teen Brains Offers Clues to Timing of Mental Illness

Posted 27 Jul 2016 by Drugs.com

WEDNESDAY, July 27, 2016 – Changes that occur in teens' brains as they mature may help explain why the first signs of mental illness tend to appear during this time, researchers report. British researchers used MRI scans to compare the brain structures of nearly 300 participants who were aged 14 to 24. The scientists discovered that the brain's outer region (cortex) becomes thinner as teens get older. At the same time, they saw that levels of myelin increased within the cortex. That increase was seen in critical regions of the brain that act as connection points between other regions. Myelin is the sheath that covers nerve fibers and enables them to communicate efficiently. "During our teenage years, our brains continue to develop. When we're still children, these changes may be more dramatic, but in adolescence we see that the changes refine the detail," explained study first author ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Bipolar Disorder, Social Anxiety Disorder, Schizophrenia, Severe Mood Dysregulation, Diagnosis and Investigation, Dependent Personality Disorder, Head Imaging

'Managing' Elderly Patients Without Powerful Antipsychotics

Posted 26 Jul 2016 by Drugs.com

MONDAY, July 25, 2016 – About 25 percent of dementia patients in U.S. nursing homes are still quieted with risky antipsychotic medications. Now, a small study suggests that managing these difficult patients, instead of medicating them, could obtain better results. "Drugs have a place, but should not be first-line treatments. They don't work well, and there are side effects," said study author Dr. Henry Brodaty, a professor of aging and mental health at the University of New South Wales in Sydney, Australia. Antipsychotic drugs such as Risperdal (risperidone), Abilify (aripiprazole) and Seroquel (quetiapine) are approved to treat serious psychiatric conditions such as bipolar disorder and schizophrenia. But in seniors, they're often used to calm aggressive or violent behavior linked to dementia. "They're basically a sedative," said Dean Hartley, director of science initiatives with the ... Read more

Related support groups: Bipolar Disorder, Seroquel, Abilify, Schizophrenia, Mania, Latuda, Risperdal, Zyprexa, Schizoaffective Disorder, Risperidone, Dementia, Geodon, Saphris, Quetiapine, Seroquel XR, Alzheimer's Disease, Olanzapine, Invega, Clozapine, Compazine

Can Trauma Trigger Violent Crime in Mentally Ill?

Posted 14 Jul 2016 by Drugs.com

WEDNESDAY, July 13, 2016 – People with serious mental illness who are victims of violence or exposed to stressful events are more likely to engage in a violent crime in the week following the trauma, a new study contends. Stressful experiences also affect people without psychiatric disorders, but not to the same extent, the researchers said. Some stressful events – such as being violently victimized, injured in an accident, losing one's parents or self-harming – act as "triggers," said study co-author Dr. Seena Fazel. He is a professor of forensic psychiatry at the University of Oxford in England. Experiencing one of these events increases the risk of committing a violent criminal act within a week of the trigger, especially in people with schizophrenia and bipolar disorder, Fazel said. People diagnosed with these conditions have higher rates of criminal convictions than the general ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Post Traumatic Stress Disorder, Social Anxiety Disorder, Schizophrenia, Paranoid Disorder, Schizoaffective Disorder, Agitation, Psychosis, Agitated State, Psychiatric Disorders, Drug Psychosis, Executive Function Disorder

Mentally Ill Still Gain Illegal Possession of Guns, Study Shows

Posted 8 Jun 2016 by Drugs.com

TUESDAY, June 7, 2016 – Almost two-thirds of violent gun crime arrests among the mentally ill were people who were already legally prohibited from having a firearm, a new study from Florida reveals. And close to one-third of the suicides carried out by the mentally ill were among people who weren't legally allowed to possess a firearm, the study found. "That's a failure of the enforcement mechanism," said study lead author Jeffrey Swanson. That troubling finding reflects a problem with the criteria for identifying individuals at risk, added Swanson, a professor with Duke University School of Medicine's department of psychiatry and behavioral sciences. Mental illness causes only a small fraction of gun violence in the United States, around 3 to 5 percent, said Colleen Barry, a professor at Johns Hopkins Bloomberg School of Public Health in Baltimore. The Duke study "does bring new ... Read more

Related support groups: Depression, Bipolar Disorder, Post Traumatic Stress Disorder, Social Anxiety Disorder, Schizophrenia, Mania, Borderline Personality Disorder, Schizoaffective Disorder, Agitation, Psychosis, Agitated State, Psychiatric Disorders, Disruptive Mood Dysregulation Disorder

Is Smoking During Pregnancy Tied to Offspring's Schizophrenia Risk?

Posted 27 May 2016 by Drugs.com

FRIDAY, May 27, 2016 – Smoking during pregnancy may increase the risk that a child could develop schizophrenia, new research suggests. "This is, so far, the largest study to show an association between prenatal nicotine exposure and schizophrenia," said study author Dr. Solja Niemela. She is a professor of psychiatry and addiction medicine at the University of Oulu, Lapland Hospital District, in Rovaniemi, Finland. Although the study didn't prove cause and effect, the finding is the first to be based on blood sample analyses that provided evidence of nicotine exposure in the womb, rather than on less reliable maternal recollections of smoking behavior, Niemela added. Still, she added that "the causes of schizophrenia are multifaceted." "It is likely that prenatal smoking exposure alone does not cause schizophrenia," said Niemela. "Rather, there is [probably] an interplay of genetic and ... Read more

Related support groups: Smoking, Schizophrenia, Schizoaffective Disorder, Smoking Cessation, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Labor and Delivery including Augmentation

FDA Medwatch Alert: Olanzapine: Drug Safety Communication - FDA Warns About Rare But Serious Skin Reactions

Posted 10 May 2016 by Drugs.com

ISSUE: FDA is warning that the antipsychotic medicine olanzapine can cause a rare but serious skin reaction that can progress to affect other parts of the body. FDA is adding a new warning to the drug labels for all olanzapine-containing products that describes this severe condition known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). A search of the FDA Adverse Event Reporting System (FAERS) database identified 23 cases of DRESS reported with olanzapine worldwide since 1996, when the first olanzapine-containing product was approved. FAERS includes only reports submitted to FDA, so there are likely to be additional cases about which FDA is unaware. One patient taking olanzapine experienced DRESS and died; however, this patient was taking multiple medicines that could also have contributed to death (see the Data Summary section of the Drug Safety Communication for more ... Read more

Related support groups: Bipolar Disorder, Schizophrenia, Zyprexa, Olanzapine, Symbyax, Zyprexa Zydis, Zyprexa Intramuscular, Fluoxetine/Olanzapine, Zyprexa Relprevv

FDA Medwatch Alert: Aripiprazole (Abilify, Abilify Maintena, Aristada): Drug Safety Communication - FDA Warns About New Impulse-control Problems

Posted 5 May 2016 by Drugs.com

ISSUE: FDA is warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of the antipsychotic drug aripiprazole (Abilify, Abilify Maintena, Aristada, and generics). These uncontrollable urges were reported to have stopped when the medicine was discontinued or the dose was reduced. These impulse-control problems are rare, but they may result in harm to the patient and others if not recognized.  Although pathological gambling is listed as a reported side effect in the current aripiprazole drug labels, this description does not entirely reflect the nature of the impulse-control risk FDA identified. In addition, FDA has become aware of other compulsive behaviors associated with aripiprazole, such as compulsive eating, shopping, and sexual actions. These compulsive behaviors can affect anyone who is taking the medicine. As a ... Read more

Related support groups: Abilify, Schizophrenia, Aripiprazole, Abilify Maintena, Abilify Discmelt, Aristada

Early Emotional Support May Help Kids Manage Feelings Later

Posted 26 Apr 2016 by Drugs.com

TUESDAY, April 26, 2016 – Preschoolers given higher levels of emotional support from moms, dads or other caregivers tend to have better emotional health during their childhood and teen years, a new study suggests. The researchers saw increased growth in a brain region known as the hippocampus in children who were highly supported at preschool age. The hippocampus is involved in emotion, learning and memory formation. Reductions in hippocampus volume have been linked with worse emotional health and unhealthy coping, the study authors said. "Support during the preschool period seems critical to healthy brain development, and healthy brain development is important for healthy emotional functioning," said study leader Dr. Joan Luby. She's a professor of child psychiatry at Washington University in St. Louis. The researchers reported that they didn't see changes in the volume of the ... Read more

Related support groups: Depression, Anxiety, Anxiety and Stress, Social Anxiety Disorder, Schizophrenia, Schizoaffective Disorder, Oppositional Defiant Disorder, Agitation, Psychosis, Dysthymia, Agitated State, Psychiatric Disorders, Executive Function Disorder

No Link Between Anti-Smoking Drugs, Mental Health Issues: Study

Posted 23 Apr 2016 by Drugs.com

FRIDAY, April 22, 2016 – The anti-smoking drugs Chantix (varenicline) and Wellbutrin (bupropion) don't appear to raise the risk of serious mental health disorders such as depression, anxiety and suicidal thoughts, a new study suggests. "Clinical guidelines recommend that the most effective way to give up smoking is smoking cessation medication and counseling. However, smokers do not use these services enough, in part due to concerns that the medications may not be safe," said lead author Dr. Robert Anthenelli, professor of psychiatry at University of California, San Diego. The new study, published April 22 in The Lancet, should help ease those concerns for patients, the researchers said. The study was requested by the U.S. Food and Drug Administration due to concerns about the safety of the drugs used to help people quit smoking. Funding was provided by drug makers Pfizer (which makes ... Read more

Related support groups: Depression, Anxiety, Anxiety and Stress, Wellbutrin, Major Depressive Disorder, Social Anxiety Disorder, Bupropion, Smoking, Chantix, Schizophrenia, Contrave, Wellbutrin XL, Smoking Cessation, Wellbutrin SR, Agitation, Nicotine, Eating Disorder, Psychosis, Zyban, Agitated State

MS Patients May Be Prone to Other Chronic Illnesses, Study Finds

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – People with multiple sclerosis (MS) are more likely to have other chronic health problems than those without the nervous system disorder, a new study indicates. Researchers looked at how common several chronic conditions – high blood pressure, diabetes, high cholesterol, heart disease, chronic lung disease, epilepsy, fibromyalgia, inflammatory bowel disease, depression, anxiety, bipolar disorder and schizophrenia – were in nearly 23,400 people newly diagnosed with MS and more than 116,600 people without MS. The MS patients had higher rates of all the conditions, with high cholesterol being the exception. Their rates of mental illness, particularly depression, were also high. Nineteen percent of MS patients and 9 percent of those without MS had depression, the study found. For many of the chronic conditions, there were significant gender differences. High ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Seizures, Hypertension, Asthma, Heart Disease, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Epilepsy, High Cholesterol, Heart Attack, Schizophrenia, Mania, Schizoaffective Disorder, Angina, Diabetic Neuropathy, Insulin Resistance, Seizure Prevention, Upper Respiratory Tract Infection, Diabetic Nerve Damage

Psychosis Plus Pot a Bad Mix: Study

Posted 4 Mar 2016 by Drugs.com

THURSDAY, March 3, 2016 – People diagnosed with psychosis will probably have a longer, harder struggle to maintain their mental health if they're regular marijuana users, British researchers report. And those who just experienced their first episode of psychotic illness are 50 percent more likely to need subsequent hospitalization for their condition if they use marijuana, according to findings published online March 3 in the journal BMJ Open. They also spend longer periods in the hospital, averaging 35 more days in mental health wards during a five-year period than those with psychosis who don't use pot. Finally, marijuana users don't seem to respond to anti-psychotic medications as well as non-users, said lead researcher Rashmi Patel, a clinical lecturer with the Department of Psychosis Studies at King's College London. "We're not entirely sure why that is, but it's possible for ... Read more

Related support groups: Schizophrenia, Mania, Agitation, Psychosis, Agitated State, Psychiatric Disorders, Cannabis, Neurosis, Depressive Psychosis, Drug Psychosis

Schizophrenia Tied to Much Higher Risk of Suicide Attempts

Posted 19 Feb 2016 by Drugs.com

THURSDAY, Feb. 18, 2016 – Schizophrenia patients are at significantly increased risk of attempting suicide, a new study finds. Researchers analyzed data from more than 21,700 Canadians, including 101 who had been diagnosed with schizophrenia. About 39 percent of people (two in five) with schizophrenia had attempted suicide, compared with about 3 percent of people without the mental health disorder. "Even after taking into account most of the known risk factors for suicide attempts, those with schizophrenia had six times the odds of having attempted suicide in comparison to those without schizophrenia," study author Esme Fuller-Thomson said in a University of Toronto news release. Fuller-Thomson is a professor of social work at the university. When researchers focused only on the 101 individuals with schizophrenia, they found that "women and those with a history of drug or alcohol abuse ... Read more

Related support groups: Depression, Wellbutrin, Seroquel, Major Depressive Disorder, Abilify, Lithium, Amitriptyline, Bupropion, Viibryd, Schizophrenia, Mirtazapine, Wellbutrin XL, Remeron, Nortriptyline, Latuda, Risperdal, Zyprexa, Elavil, Schizoaffective Disorder, Risperidone

Scientists Uncover Clues to Origins of Schizophrenia

Posted 27 Jan 2016 by Drugs.com

WEDNESDAY, Jan. 27, 2016 – Some people might develop schizophrenia when a normal process of brain development goes haywire in adolescence and early adulthood, Harvard researchers report. Everyone undergoes what is called "synaptic pruning" as they move into adulthood, explained study author Steven McCarroll, director of genetics for the Broad Institute's Stanley Center for Psychiatric Research and an associate professor of genetics at Harvard Medical School in Boston. It's how extra brain cells and synapses (the junctions where nerve signals cross from one brain cell to the next) are eliminated in the cerebral cortex, to increase the efficiency of function, he said. But a gene that contributes to synaptic pruning may increase a person's risk of schizophrenia if certain mutations cause things to go wrong, McCarroll and his colleagues explained. "Somehow, this biological process becomes ... Read more

Related support groups: Schizophrenia, Schizoaffective Disorder, Diagnosis and Investigation

Mouse Study May Offer Clues to Mysteries of Schizophrenia

Posted 6 Jan 2016 by Drugs.com

WEDNESDAY, Jan. 6, 2016 – Results of experiments with mice may help shed light on some of the harder-to-treat symptoms of schizophrenia in humans, a new study suggests. Schizophrenia is a severe mental illness that affects about one in every 100 adults worldwide, according to background notes with the study. Researchers at Columbia University Medical Center in New York City found that the loss of certain cells in a previously unexplored area of the brain's memory center may be linked with the disabling disease. Specifically, the investigators said a decrease in the number of so-called inhibitory neurons in a tiny area of the hippocampus may play a role in stubborn symptoms such as social withdrawal, low levels of motivation and emotional problems. It's long been thought that schizophrenia originates in the hippocampus, the brain region that handles memory. Nearly every part of the ... Read more

Related support groups: Schizophrenia, Schizoaffective Disorder

Page 1 2 3 4 5 6 7 8 9 Next

Ask a Question

Further Information

Related Condition Support Groups

Schizoaffective Disorder, Psychiatric Disorders

Related Drug Support Groups

Seroquel, Abilify, Latuda, Zyprexa, Risperdal, risperidone, Geodon, Saphris, quetiapine, view more... Seroquel XR, olanzapine, Invega, clozapine, Rexulti, aripiprazole, Clozaril, Thorazine, Zyprexa Zydis, ziprasidone, Fanapt, chlorpromazine, Invega Sustenna, asenapine, Navane, Stelazine, paliperidone, Risperdal Consta, thioridazine, Mellaril, loxapine, brexpiprazole, thiothixene, iloperidone, Vraylar, trifluoperazine, lurasidone, Abilify Maintena, Risperdal M-Tab, Abilify Discmelt, Sparine, Loxitane, reserpine, Aristada, Moban, Zyprexa Intramuscular, Zyprexa Relprevv, Loxitane IM, Versacloz, Adasuve, Invega Trinza, FazaClo, molindone, Ormazine, mesoridazine, cariprazine, promazine, Clopine, Clozapine Synthon, Serentil, Mellaril-S, Zaponex, Denzapine, Loxitane C